NewsHealth & MedicineA new kind of non-opioid painkiller gets FDA approvalThe oral drug, called Journavx, is meant to treat short-term pain A new oral drug called Journavx is intended for the treatment of short-term pain, such as following surgery or another tissue injury.Vertex PharmaceuticalsBy Aimee Cunningham28 seconds agoPatients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.On January 30, the U.S. Food and Drug Administration approved suzetrigine for the treatment of moderate to severe pain in adults. The oral drug, called Journavx, is meant to ease short-term pain, the type that follows tissue injury, such as after surgery. The first of a new class of pain therapies to be approved in decades, the drug doesnt pose a risk of addiction as opioid medications do, evidence suggests.